<PAGE> 1
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement [ ] Confidential, for Use of the
[x] Definitive Proxy Statement Commission Only (as permitted by
[ ] Definitive Additional Materials Rule 14a-6(e)(2))
[ ] Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
K-Tron International, Inc.
------------------------------------------------------------------
(NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
------------------------------------------------------------------------
(NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
1) Title of each class of securities to which transaction applies:
------------------------------------------------------------------------
2) Aggregate number of securities to which transaction applies:
------------------------------------------------------------------------
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
------------------------------------------------------------------------
4) Proposed maximum aggregate value of transaction:
------------------------------------------------------------------------
5) Total fee paid:
------------------------------------------------------------------------
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
------------------------------------------------------------------------
2) Form, Schedule or Registration Statement No.:
------------------------------------------------------------------------
3) Filing Party:
------------------------------------------------------------------------
4) Dated Filed:
------------------------------------------------------------------------
<PAGE> 2
K-TRON INTERNATIONAL, INC.
Routes 55 and 553
P.O. Box 888
Pitman, New Jersey 08071-0888
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD MAY 5, 1998
To Our Shareholders:
Notice is hereby given that the Annual Meeting of Shareholders of
K-Tron International, Inc. (the "Company") will be held on May 5, 1998 at 10:00
a.m., local time, at the Rosemont Suites Hotel O'Hare, 5500 N.
River Road, Rosemont, Illinois for the following purposes:
(1) To elect two directors to Class I of the Board of Directors, each
to serve for a four-year term and until the election and qualification of his or
her successor;
(2) To approve an amendment to and restatement of the Company's 1996
Equity Compensation Plan;
(3) To approve an increase in the number of authorized shares of Common
Stock under the Company's Restated Certificate of Incorporation; and
(4) To transact such other business as may properly come before the
meeting.
Only shareholders of record at the close of business on March 10, 1998
are entitled to notice of the Annual Meeting and to vote at the Annual Meeting
and any adjournments thereof. The transfer books will not be closed.
By Order of the Board of Directors,
Mary E. Vaccara
Assistant Secretary
March 23, 1998
YOUR PROXY VOTE IS IMPORTANT. ACCORDINGLY, YOU ARE ASKED TO COMPLETE,
SIGN AND RETURN THE ACCOMPANYING PROXY CARD IN THE ENVELOPE PROVIDED
WHICH REQUIRES NO POSTAGE IF MAILED IN THE UNITED STATES.
<PAGE> 3
[K-TRON LOGO]
K-TRON INTERNATIONAL
PROXY STATEMENT
ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD MAY 5, 1998
This Proxy Statement is being furnished to the shareholders of K-Tron
International, Inc. (the "Company") in connection with the Annual Meeting of
Shareholders of the Company to be held on May 5, 1998 and any adjournments
thereof (the "Annual Meeting"). This Proxy Statement and the enclosed Proxy Card
are being mailed to shareholders on or about March 23, 1998.
Execution and return of the enclosed Proxy Card are being solicited by
and on behalf of the Board of Directors of the Company for the purposes set
forth in the foregoing notice of meeting. The costs incidental to the
solicitation and obtaining of proxies, including the cost of reimbursing banks
and brokers for forwarding proxy materials to their principals, will be borne by
the Company. Proxies may be solicited, without extra compensation, by officers
and employees of the Company by mail, telephone, telefax, personal interviews
and other methods of communication.
The Annual Report to Shareholders for the fiscal year ended January 3,
1998, including consolidated financial statements and other information with
respect to the Company and its subsidiaries, is being mailed to shareholders
with this Proxy Statement. Such Annual Report is not part of this Proxy
Statement.
VOTING AT THE MEETING
RECORD DATE; VOTE REQUIRED; PROXIES
Only shareholders of record at the close of business on March 10, 1998
are entitled to notice of the Annual Meeting and to vote at the Annual Meeting.
As of that date, the Company had outstanding 3,245,314 shares of Common Stock.
The holders of a majority of such shares, represented in person or by proxy,
shall constitute a quorum at the Annual Meeting. A quorum is necessary before
business may be transacted at the Annual Meeting except that, even if a quorum
is not present, the shareholders present in person or by proxy shall have the
power to adjourn the meeting from time to time until a quorum is present. Each
shareholder entitled to vote shall have the right to one vote for each share of
Common Stock outstanding in such shareholder's name.
The shares of Common Stock represented by each properly executed Proxy
Card will be voted at the Annual Meeting in the manner directed therein by the
shareholder signing such Proxy Card. The Proxy Card provides spaces for a
shareholder to vote for the nominees, or to withhold authority to vote for both
nominees or either nominee, for the Board of Directors and also to vote for or
against or to abstain from voting with respect to the proposals to amend and
restate the Company's 1996 Equity Compensation Plan and to amend the Company's
Restated Certificate of Incorporation. The nominees for election as directors
are to be elected by a plurality of the votes cast at the Annual Meeting, the
amendment to and restatement of the Company's 1996 Equity Compensation
<PAGE> 4
Plan requires the affirmative vote of a majority of the votes cast by
shareholders entitled to vote thereon and the amendment to the Company's
Restated Certificate of Incorporation requires the affirmative vote of at least
two-thirds of the votes cast by shareholders entitled to vote thereon. With
respect to any other matter that may properly be brought before the Annual
Meeting, the affirmative vote of a majority of the votes cast by shareholders
entitled to vote thereon is required to take action, unless a greater percentage
is required either by law or by the Company's Restated Certificate of
Incorporation or By-Laws. For determining the number of votes cast with respect
to any voting matter, only those cast "for" or "against" are included.
With regard to the election of directors, votes may be cast in favor of
or withheld from any or all nominees. Votes that are withheld will be excluded
entirely from the vote and will have no effect, other than for purposes of
determining the presence of a quorum. Abstentions may be specified on the
proposals to amend and restate the Company's 1996 Equity Compensation Plan and
to amend the Company's Restated Certificate of Incorporation (but not for the
election of directors). Abstentions will be considered present and entitled to
vote at the Annual Meeting but will not be counted as votes cast. Accordingly,
abstentions will have no effect on the vote. In addition, where brokers submit
proxies but are prohibited and thus refrain from exercising discretionary
authority in voting shares on certain matters for beneficial owners who have not
provided voting instructions with respect to such matters (commonly referred to
as "broker non-votes"), those shares will be considered present and entitled to
vote at the Annual Meeting but will not be counted as votes cast as to such
matters. Accordingly, broker non-votes also will have no effect on the vote.
If a signed Proxy Card is returned and the shareholder has given no
direction with respect to a voting matter, the shares will be voted with respect
to that matter by the proxy agents as recommended by the Board of Directors or
its Executive Committee. Execution and return of the enclosed Proxy Card will
not affect a shareholder's right to attend the Annual Meeting and vote in
person. Any shareholder giving a proxy has the right to revoke it by giving
notice of revocation to the Secretary of the Company at any time before the
proxy is voted.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information as of March 10, 1998
(or as of such other date as may be noted below) with respect to shares of
Common Stock of the Company beneficially owned by each person believed by the
Company to be the beneficial owner of more than 5% of the outstanding shares of
Common Stock, by each director of the Company, by each executive officer of the
Company who was serving as such on January 3, 1998 and by all current directors
and executive officers of the Company as a group. Except as indicated below, the
Company understands that the shareholders listed in such table have sole voting
and investment power with respect to the shares owned by them. The number of
shares in the table below includes shares issuable upon the exercise of
outstanding stock options to the extent that such options are exercisable by the
shareholder, director or executive officer on or within 60 days after March 10,
1998. In the case of current directors and executive officers, the information
below has been provided by them at the request of the Company.
2
<PAGE> 5
<TABLE>
<CAPTION>
Number of Shares Percent of Common
Name of Individual or Identity of Group of Common Stock Stock Outstanding
- --------------------------------------- --------------- -----------------
<S> <C> <C>
Estate of Dr. Mario Gallo(1)................... 457,400 14.1
David L. Babson & Company, Incorporated(2)..... 340,330 10.4
T. Rowe Price Associates, Inc.(3).............. 250,000 7.7
Paradigm Capital Management, Inc. (4).......... 181,200 5.6
Dimensional Fund Advisors Inc.(5).............. 162,400 5.0
Edward B. Cloues, II(6)........................ 85,714 2.6
Leo C. Beebe(7)................................ 60,385 1.9
Robert L. Weinberg(6)(8)....................... 30,190 *
Dr. Hans-Jurg Schurmann(6)..................... 21,000 *
Johannes Wirth................................. 16,400 *
Richard J. Pinola(6)........................... 15,114 *
Kevin C. Bowen(6).............................. 13,654 *
Jean Head Sisco(6)............................. 12,801 *
Lukas Gunthardt(6)............................. 8,352 *
Norman Cohen................................... 7,219 *
All current directors and executive officers
as a group (10 persons)(9)................... 270,829 8.1
</TABLE>
- ----------
* Less than 1%.
(1) As reflected in a Schedule 13G dated January 27, 1982, except that Dr.
Gallo is deceased and the Company believes the shares are now held by
Dr. Gallo's estate. The most recent address known to the Company for
the Estate of Dr. Gallo was c/o Burckhardt, Treuhand & Revisions AG,
Postfach, Scheideggstrasse 73, CH-8038, Zurich, Switzerland.
(2) As reflected in Schedule 13G/A dated January 15, 1998. According to
David L. Babson & Company, Incorporated ("Babson"), it (i) is an
investment adviser and (ii) has sole voting and dispositive power over
all such shares. The principal address of Babson is One Memorial Drive,
Cambridge, Massachusetts 02142-1300.
(3) As reflected in Amendment No. 5 to Schedule 13G dated February 12,
1998. According to T. Rowe Price Associates, Inc. ("Price Associates"),
these shares are all owned by T. Rowe Price Small Cap Value Fund, Inc.,
a registered investment company, for which Price Associates, a
registered investment adviser under the Investment Advisers Act of
1940, serves as investment adviser with power to direct investments
and/or sole power to vote the shares. For purposes of the reporting
requirements of the Securities Exchange Act of 1934, as amended, Price
Associates is deemed to be a beneficial owner of such shares; however,
Price Associates expressly disclaims that it is, in fact, the
beneficial owner of such shares. The principal address of Price
Associates is 100 East Pratt Street, Baltimore, Maryland 21202.
(4) As reflected in Amendment No. 1 to Schedule 13G dated February 11,
1998. According to Paradigm Capital Management, Inc. ("Paradigm"), it
(i) is a registered investment adviser and (ii) has sole dispositive
power over all such shares. The principal address of Paradigm is Nine
Elk Street, Albany, New York 12207.
(5) As reflected in Amendment No. 5 to Schedule 13G dated January 31, 1995.
According to Dimensional Fund Advisors Inc. ("Dimensional"), a
registered investment adviser under the Investment Advisers Act of
1940, it was deemed to have beneficial ownership of 162,400 shares as
of December 31, 1994, all of which
3
<PAGE> 6
shares were held in portfolios of DFA Investment Dimensions Group Inc.,
a registered open-end investment company, or in a series of the DFA
Investment Trust Company, a Delaware business trust company, or the DFA
Group Trust and the DFA Participation Group Trust, investment vehicles
for qualified employee benefit plans, as to all of which Dimensional
serves as investment manager. Dimensional disclaims beneficial
ownership of all such shares. The principal address of Dimensional is
1299 Ocean Avenue, 11th Floor, Santa Monica, California 90401.
(6) Includes with respect to Mr. Cloues 35,714 shares, Mr. Weinberg 20,500
shares, Dr. Schurmann 10,000 shares, Mr. Pinola 10,000 shares, Mr.
Bowen 9,750 shares, Mrs. Sisco 8,900 shares and Mr. Gunthardt 6,500
shares, all of which shares are subject to presently exercisable
installments of options.
(7) With respect to all such shares, Mr. Beebe shares investment and voting
power with his wife.
(8) Includes 2,000 shares owned by Mr. Weinberg's wife, as to which Mr.
Weinberg disclaims beneficial ownership, and includes 2,592 shares as
to which Mr. Weinberg shares investment and voting power with his wife.
(9) Includes 101,364 shares subject to presently exercisable installments
of options.
MATTERS CONCERNING DIRECTORS
ELECTION OF DIRECTORS
The Board of Directors currently consists of seven directors and is
classified with respect to terms of office into four classes. Each Class I
director elected at the Annual Meeting will serve until the 2002 annual meeting
of shareholders and until such director's successor has been elected and
qualified, except in the event of such director's earlier death, resignation or
removal. The terms of office of the Class II, Class III and Class IV directors
will expire at the annual meetings to be held in 1999, 2000 and 2001,
respectively, upon the election and qualification of their successors.
The Board of Directors, acting on the recommendation of its Nominating
Committee, has nominated Dr. Hans-Jurg Schurmann and Mrs. Jean Head Sisco for
election as the Class I directors.
The persons named as proxy agents in the enclosed Proxy Card intend
(unless instructed otherwise by a shareholder) to vote for the election of Dr.
Hans-Jurg Schurmann and Mrs. Jean Head Sisco as the Class I directors. In the
event that a nominee should become unable to accept nomination or election (a
circumstance which the Board of Directors does not expect), the proxy agents
intend to vote for any alternate nominee designated by the Board of Directors or
its Executive Committee or, in the discretion of the Board or its Executive
Committee, the position may be left vacant.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR EACH CLASS I
NOMINEE.
Set forth below is certain information with respect to each nominee for
director and each other person currently serving as a director of the Company
whose term of office will continue after the Annual Meeting, including the class
and term of office of each such person. This information has been provided by
each director at the request of the Company.
Class I--Nominees for Terms Continuing until 2002
DR. HANS-JURG SCHURMANN. Dr. Schurmann has been a director since
November 1993 and was most recently reelected at the 1994 annual meeting of
shareholders. He is a senior partner in the law firm of Schurmann,
4
<PAGE> 7
Rausch & Rohrer in Zurich, Switzerland, which represents the Company and its
subsidiaries in Switzerland, and he has been a partner in that firm since 1979.
Dr. Schurmann serves on the boards of numerous European companies, including
Instinet AG (Switzerland), Bellaplast Holding AG (Switzerland) and Discorack-NCO
AG (Switzerland). Dr. Schurmann is 53 years of age.
JEAN HEAD SISCO. Mrs. Sisco has been a director since September 1993
and was most recently reelected at the 1994 annual meeting of shareholders.
Since 1979, she has been a partner in Sisco Associates, a management consulting
firm based in Washington, D.C. which specializes in international risk and trade
analysis. Mrs. Sisco serves as a director of Textron, Inc., Newmont Mining
Corp., Newmont Gold Corp., Chiquita Brands International, The Neiman-Marcus
Group and American Funds Tax-Exempt Series II. She is Chairman of the Center for
Board Leadership and was the first woman director of the Metropolitan Washington
Board of Trade. Mrs. Sisco is 72 years of age.
Class II--Director with Term Continuing until 1999
JOHANNES WIRTH. Mr. Wirth has been a director since May 1978 and was
most recently reelected at the 1995 annual meeting of shareholders. Since
January 1997, he has from time to time served as a consultant in measurement
technology. From November 1993 until the end of 1996, Mr. Wirth was a part-time
employee of Digisens SA, a manufacturer of weighing systems, and from time to
time served as a consultant in measurement technology. Since 1983, he has been
an owner and Managing Director of Wirth Gallo Messtechnik AG, a Swiss research
firm specializing in weighing and measuring techniques, which ceased active
operations in late 1993. Mr. Wirth also served as a consultant to the Company
from April 1991 through December 1995. Mr. Wirth is 66 years of age.
Class III--Directors with Terms Continuing until 2000
NORMAN COHEN. Mr. Cohen has been a director since 1974 and was most
recently reelected at the 1996 annual meeting of shareholders. He was a
consultant in the clothing business from 1991 until 1993, and since 1993 has
been Chairman and Chief Executive Officer of Creative Contracting Associates,
Inc., a clothing manufacturer. Mr. Cohen filed a petition under chapter 7 of the
federal Bankruptcy Code in the United States Bankruptcy Court for the Middle
District of Florida in September 1993, and was discharged in January 1994. Mr.
Cohen is 71 years of age.
RICHARD J. PINOLA. Mr. Pinola has been a director since January 1994
and was most recently reelected at the 1996 annual meeting of shareholders.
Since January 1994, he has served as Chairman and Chief Executive Officer of
Right Management Consultants, Inc., a publicly-held human resource consulting
and career management firm, and from June 1992 through December 1993 he was
President and Chief Executive Officer of that company. Prior to joining Right
Management Consultants, Inc., Mr. Pinola was President and Chief Operating
Officer of Penn Mutual Life Insurance Company from March 1988 through September
1991 and a consultant from September 1991 until June 1992. He serves as a
director of Right Management Consultants, Inc. and Epitaxx, Inc. Mr. Pinola is
52 years of age.
Class IV--Directors with Terms Continuing until 2001
LEO C. BEEBE. Mr. Beebe has been a director since June 1976 and was
most recently reelected as a director at the 1997 annual meeting of
shareholders. From July 1985 until August 1992 and again from June 1995 until he
retired in January 1998, Mr. Beebe was the Chief Executive Officer of the
Company, and from January 1985 until January 1998, he served as the Chairman of
the Board of Directors of the Company. Mr. Beebe was Dean of the School of
Business Administration of Glassboro State College, Glassboro, New Jersey from
July 1977 to July 1985 and a professor of marketing at Glassboro State College
from 1972 to July 1985. Prior to that time, he served at Ford Motor Company for
27 years in various capacities in the United States and foreign countries,
including as General Marketing Manager of Ford's Lincoln-Mercury Division, Vice
President of Marketing and
5
<PAGE> 8
Planning and a director of Ford Motor Company of Canada, and Executive Vice
President and General Manager of the Consumer Products Division and a director
of Philco Ford Corporation. Mr. Beebe is 80 years of age.
EDWARD B. CLOUES, II. Mr. Cloues has been a director since July 1985
and was most recently reelected at the 1997 annual meeting of shareholders. He
became Chairman of the Board of Directors and Chief Executive Officer of the
Company on January 5, 1998. Since May 1985, Mr. Cloues has served as Secretary
of the Company. Prior to joining the Company, Mr. Cloues was a senior partner in
the law firm of Morgan, Lewis & Bockius LLP, which is the Company's general
counsel. He is also a director and non-executive Chairman of the Board of AMREP
Corporation. Mr. Cloues is 50 years of age.
COMMITTEES AND MEETINGS
The Board of Directors has an Executive Committee, an Audit and Finance
Committee, a Compensation and Human Resources Committee and a Nominating
Committee. The members of the Compensation and Human Resources Committee also
constitute the members of the two committees which administer the Company's
employee stock option plans (collectively, the "Stock Option Committee"). During
fiscal year 1997, the Board of Directors held seven meetings, the Executive
Committee held one meeting (by conference telephone), the Audit and Finance
Committee held two meetings, the Compensation and Human Resources Committee held
two meetings (including one by conference telephone), the Nominating Committee
held one meeting and the Stock Option Committee did not meet separately from the
Compensation and Human Resources Committee. Each director attended at least 75%
of the aggregate of the meetings of the Board of Directors held during fiscal
year 1997 and of the committee or committees on which he or she served during
the year.
The Executive Committee is empowered to exercise all powers of the
Board of Directors, except action on dividends and certain other matters which
cannot by law be delegated by the Board, during the periods between regular
Board meetings. The Audit and Finance Committee is responsible for recommending
to the Board the firm to be employed by the Company as its independent
accountants and auditors, consulting with such firm as to the annual audit and
the adequacy of internal controls, reviewing the accounting controls, practices
and policies of the Company and reviewing budgets, cash and debt management and
financial matters generally. The Compensation and Human Resources Committee
recommends to the Board the compensation of the Company's chief executive
officer, reviews and takes action on the chief executive officer's
recommendations regarding the appropriate compensation of the Company's other
officers and key personnel, approves the granting of any bonuses to officers,
reviews other compensation and personnel development matters generally and
recommends to the Board the compensation of non-employee directors. The
Nominating Committee's duties are to evaluate Board performance, recommend to
the Board nominees for election as directors and recommend to the Board the
membership of all Board committees. The Stock Option Committee is responsible
for administering the Company's 1996 Equity Compensation Plan and another stock
option plan which has expired, but under which there remain outstanding stock
options.
The current members of the Executive Committee are Messrs. Cloues
(Chairman), Beebe and Cohen; of the Audit and Finance Committee, Messrs. Pinola
(Chairman) and Wirth, Dr. Schurmann and Mrs. Sisco; of the Compensation and
Human Resources Committee, Messrs. Cohen (Chairman) and Pinola and Mrs. Sisco;
of the Nominating Committee, Messrs. Beebe (Chairman) and Cloues; and of the
Stock Option Committee, Messrs. Cohen and Pinola and Mrs. Sisco.
STANDARD COMPENSATION ARRANGEMENTS
Directors who are not employees of the Company receive an annual
retainer of $12,500, a $2,000 annual retainer for each membership on any of the
Audit and Finance Committee, the Compensation and Human Resources Committee and
the Nominating Committee, a $1,000 annual retainer for membership on the
Executive Committee, $1,000 for each Board meeting attended and $750 for each
Executive Committee meeting attended provided that, in the case of Executive
Committee meetings, such meetings either require substantial preparation or last
two hours or
6
<PAGE> 9
more. In addition, the chairman of the Audit and Finance Committee and the
chairman of the Compensation and Human Resources Committee are each paid an
additional $1,500 for their service in such capacities. All retainers are paid
on a prorated bi-monthly basis. Directors generally do not receive compensation
for their participation in telephone meetings or for attendance at other
committee meetings.
Non-employee directors are also eligible to receive a bonus in an
amount to be determined by the Compensation and Human Resources Committee at the
same time that executive bonuses, if any, are determined by that Committee. It
is contemplated that any such director bonuses would thus be related to
corporate performance on a basis similar to that used by the Compensation and
Human Resources Committee to relate senior executive bonuses to corporate
performance. A $5,000 bonus was awarded to each non-employee director for fiscal
year 1997. Such bonus was recommended by the Compensation and Human Resources
Committee and approved by the full Board. Two directors elected to have this
bonus paid in unregistered shares of Company Common Stock based on the closing
price of the Common Stock on the day that the bonus was approved. Under the
proposal to amend and restate the 1996 Equity Compensation Plan, each
non-employee director will receive an annual stock option grant to purchase
1,000 shares of Common Stock that will be exercisable in full on the date of
grant. It is anticipated that if the amendment to and restatement of the 1996
Equity Compensation Plan is approved by shareholders, the existing practice with
respect to director bonuses will terminate.
In addition, under the Company's 1988 Non-Employee Directors Stock
Option Plan (the "1988 Plan"), each director of the Company who is neither an
employee of the Company nor the beneficial owner of 3% or more of its
outstanding Common Stock receives, upon his or her election as a director, a
single nonqualified stock option to purchase 10,000 shares of Common Stock
during the ten-year term of the option at an exercise price equal to the fair
market value of such stock as of the date of option grant. This option vests and
becomes exercisable as follows: 2,500 shares on each of the dates of grant and
the first three anniversaries thereof, provided that the option holder is a
director on each vesting date. The 1988 Plan will terminate on November 18,
1998.
SHARE OWNERSHIP GUIDELINE
Each non-employee director is required to own shares of Company Common
Stock with a value, at the greater of cost or market, equal to four times the
current $12,500 annual retainer, or $50,000. As for any newly-elected director,
this requirement will be phased in over a period of time to be determined in the
future.
REQUIREMENTS FOR ADVANCE NOTIFICATION OF NOMINATIONS
Article Ninth of the Restated Certificate of Incorporation of the
Company provides that no person may be nominated for election as a director by a
shareholder at an annual or special meeting unless written notice of such
shareholder's intent to make such nomination has been given, either by personal
delivery or by United States mail, postage prepaid, to the Secretary of the
Company at the principal executive offices of the Company not later than (i)
with respect to an election to be held at an annual meeting of shareholders, 90
days in advance of such meeting and (ii) with respect to an election to be held
at a special meeting of shareholders for the election of directors, the close of
business on the seventh day following the date on which notice of such meeting
is first given to shareholders. Each such notice shall set forth: (a) the name
and address of the shareholder who intends to make the nomination and of the
person or persons to be nominated; (b) a representation that the shareholder is
a holder of record of stock of the Company entitled to vote at such meeting and
intends to appear in person or by proxy at the meeting to nominate the person or
persons specified in the notice; (c) a description of all arrangements or
understandings between the shareholder and each nominee and any other person or
persons (naming such person or persons) pursuant to which the nomination or
nominations are to be made by the shareholder; (d) such other information
regarding each nominee proposed by such shareholder as would be required to be
included in a proxy statement filed pursuant to the proxy rules of the
Securities and Exchange Commission had the nominee been nominated, or intended
to be nominated, by the Board of Directors; and (e) the consent of each nominee
to serve as a director of the Company if so elected. The chairman of the meeting
may refuse to acknowledge the nomination of any person not made in compliance
with the foregoing procedure.
7
<PAGE> 10
APPROVAL OF AMENDMENT TO AND RESTATEMENT OF THE
COMPANY'S 1996 EQUITY COMPENSATION PLAN
On March 13, 1998, the Board of Directors adopted an amendment to and
complete restatement of (the "amendment") the Company's 1996 Equity Compensation
Plan, as previously amended, to (i) increase the number of shares of Common
Stock authorized to be issued thereunder from 450,000 shares to 600,000 shares,
(ii) allow members of the Board of Directors who are not employees of the
Company ("non-employee directors") to receive stock options thereunder and (iii)
provide that, unless the committee which administers the 1996 Equity
Compensation Plan determines otherwise, each non-employee director will receive
an annual option grant of 1,000 shares of Common Stock, with an option price
equal to the fair market value of the Common Stock on the date of grant. The
amendment was adopted subject to shareholder approval at the Annual Meeting. The
principal terms of the 1996 Equity Compensation Plan, as amended and restated by
the amendment (the "Plan"), are summarized below. A copy of the Plan is attached
as Exhibit A.
1996 EQUITY COMPENSATION PLAN
The Plan is intended to encourage participants to contribute to the
long-term growth of the Company, to align their interests with those of the
Company's shareholders and to aid the Company and its subsidiaries in attracting
and retaining officers, employees and directors of outstanding ability. The Plan
is administered by a committee (the "Committee") currently comprised of the same
independent, non-employee directors who are the members of the Compensation and
Human Resources Committee of the Board of Directors. All employees of the
Company and all non-employee directors are eligible to receive grants under the
Plan. The Plan provides for the grant of stock options, stock appreciation
rights and restricted stock. As of March 13, 1998, approximately 490 employees
were eligible to receive grants under the Plan, and options to purchase 149,000
shares of Common Stock had been issued to employees and were outstanding under
the Plan.
The Plan authorizes an aggregate of 600,000 shares of Common Stock to
be issued thereunder (subject to adjustments for stock splits, stock dividends
and certain other circumstances). If any grants under the Plan expire, lapse or
terminate unexercised, or if shares of restricted stock are forfeited, the
shares may again be subject to a grant under the Plan. The maximum number of
shares of Common Stock that may be subject to grants made under the Plan to any
employee during a one-year period is 100,000 shares.
The Plan permits the Committee to grant nonqualified stock options,
incentive stock options, stock appreciation rights and restricted stock to
employees. The Plan also permits the Committee to grant nonqualified stock
options to non-employee directors. The Committee will establish the terms of the
grants, including vesting and exercise periods. The option price for stock
options may be equal to, greater than or less than the fair market value of the
Common Stock on the date of grant, and the option period shall not exceed ten
years from the date of grant. An optionee may pay the option price (i) in cash,
(ii) with the approval of the Committee, by delivering shares of previously
owned Common Stock, or (iii) through a combination of the two. Except as
otherwise determined by the Committee, options shall not be transferable except
by will or the laws of descent and distribution.
Under the Plan, the Committee may grant nonqualified stock options to
non-employee directors as it deems appropriate. Unless the Committee determines
otherwise, on the date of each annual meeting of shareholders, beginning with
the 1998 meeting, each non-employee director who is elected to the Board or
continues on the Board will be granted an option to purchase 1,000 shares of
Common Stock. The option price will be the fair market value of the Common Stock
on the date of grant. The annual grants will be fully vested on the date of
grant and will have a term of ten years. If a director ceases to be a member of
the Board for any reason other than disability, death or becoming an employee of
the Company, the director's options generally may be exercised within 90 days
after he or she ceases to be a director. Options are generally exercisable
within one year after a director ceases to be a director on account of
disability or death. If the director ceases to be a member of the Board but
becomes or remains an employee of the Company, the director's options generally
may be exercised up to 90 days after he or she ceases to
8
<PAGE> 11
be an employee of the Company. If a director becomes an employee and also
continues as a director, he or she will not be eligible to receive stock option
grants to non-employee directors but his or her existing options will not be
affected.
In the event of a change of control of the Company, unless the
Committee determines otherwise, options shall be fully exercisable and
restrictions on restricted stock shall lapse. If the Company is not the
surviving corporation (or survives only as a subsidiary of another corporation),
unless the Committee determines otherwise, outstanding options shall be assumed
by or replaced with comparable options by the surviving corporation. The Plan
permits the Committee, upon a change of control, to pay optionees the "spread"
(the difference between the fair market value at the date of payment and the
option price) with respect to outstanding options.
The Board of Directors may amend the Plan as it deems appropriate,
except that the Board may not, without shareholder approval, amend the Plan (i)
to increase the aggregate number of shares (or individual grant limit for any
single optionee) that may be issued under the Plan (other than by operation of
the adjustment provisions in the event of certain corporate transactions), (ii)
to modify the requirements as to eligibility for participation in the Plan or
(iii) in a manner for which shareholder approval is required under Section
162(m) of the Internal Revenue Code of 1986, as amended (the "Code").
FEDERAL INCOME TAX TREATMENT
Under the Code, as currently in effect, a director or employee
receiving nonqualified stock options under the Plan will not recognize income
when the options are granted. The optionee will recognize ordinary income upon
the exercise of a nonqualified stock option to the extent that the fair market
value of the shares at the time of exercise exceeds the option price. The
Company is generally entitled to a corresponding deduction for federal income
tax purposes when an optionee exercises a nonqualified stock option.
Incentive stock options ("ISOs") may only be granted to employees. An
employee will not recognize federal taxable income upon the grant or exercise of
an ISO. However, the option "spread" is generally includable for alternative
minimum tax purposes in the year in which an ISO is exercised. An employee who
disposes of the shares acquired upon exercise of an ISO after two years from the
date the ISO was granted and one year from the date such shares were transferred
to him or her upon exercise of the ISO will recognize capital gain or loss in
the amount of the difference between the amount realized on the sale and the
exercise price. As a general rule, if an employee disposes of the shares
acquired upon exercise of an ISO before satisfying both holding period
requirements (a "disqualifying disposition"), his or her gain recognized on the
disposition will be taxed as ordinary income to the extent of the difference
between the fair market value of such shares on the date of exercise and the
option price. The gain, if any, in excess of the amount recognized as ordinary
income on such a disqualifying disposition will be capital gain. The tax rate
applicable to any capital gain depends on the length of time the employee held
the shares prior to disposition. The Company generally will not be entitled to a
tax deduction when an optionee exercises an ISO, unless a disqualifying
disposition occurs.
An employee generally will not recognize taxable income upon receiving
a restricted stock grant, and the Company will not be entitled to a deduction,
until the stock is transferable by the employee or no longer subject to a
substantial risk of forfeiture. When the stock is either transferable or no
longer subject to a substantial risk of forfeiture, the employee will recognize
ordinary compensation income in an amount equal to the then fair market value of
the shares subject to the restricted stock grant (less any amount paid for such
shares), and the Company will be entitled to a corresponding tax deduction. An
employee may elect to recognize ordinary compensation income in the year the
restricted stock is granted, in which case the Company will be entitled to a
corresponding deduction in the same year.
An employee will not recognize income upon the grant of a stock
appreciation right ("SAR"). Upon the exercise of an SAR, an employee will
recognize ordinary compensation income in the amount of the cash and the
9
<PAGE> 12
fair market value of the stock received upon such exercise, and the Company will
be entitled to a corresponding deduction.
As of March 13, 1998, the closing price of the Company's Common Stock
as reported on the National Market segment of The Nasdaq Stock Market was
$17.125.
NEW PLAN BENEFITS TABLE
If the Plan is approved by shareholders at the Annual Meeting, the
following summarizes the benefits to be received thereunder by non-employee
directors as a group during 1998.
NEW PLAN BENEFITS
1996 EQUITY COMPENSATION PLAN
Name and Position Aggregate Number of Shares
----------------- --------------------------
Non-Employee Director Group 6,000
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR THE PROPOSAL
TO AMEND AND RESTATE THE COMPANY'S 1996 EQUITY COMPENSATION PLAN TO, AMONG OTHER
THINGS, INCREASE THE NUMBER OF SHARES AUTHORIZED THEREUNDER AND PROVIDE FOR
STOCK OPTION GRANTS TO NON-EMPLOYEE DIRECTORS.
APPROVAL OF AMENDMENT TO THE COMPANY'S RESTATED CERTIFICATE OF
INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK
INTRODUCTION
On March 13, 1998, the Board of Directors unanimously adopted a
resolution declaring it advisable to amend the Company's Restated Certificate of
Incorporation (the "Restated Certificate of Incorporation") to increase the
number of shares of stock that the Company has the authority to issue to an
aggregate of 51,000,000 shares, of which 50,000,000 would be Common Stock, $.01
par value per share, and 1,000,000 would continue to be Preferred Stock, $.01
par value per share (the "Amendment"). The Amendment was adopted subject to
shareholder approval at the Annual Meeting. In the event the Amendment is
approved by shareholders, the Company will thereafter amend the Restated
Certificate of Incorporation by making a filing with the Secretary of State of
the State of New Jersey reflecting the Amendment, which will become effective on
the date the filing is accepted by the Secretary of State.
CURRENT USE OF SHARES
As of March 13, 1998, the Company had 3,245,314 shares of Common Stock
outstanding and 755,113 shares reserved for possible future issuance under the
Company's stock option and employee stock purchase plans, of which 312,534 are
covered by outstanding options and 442,579 are available for future grant or
purchase. Based upon the foregoing number of outstanding and reserved shares of
Common Stock, the Company currently has 10,999,573 shares of Common Stock
available for other purposes, including for possible future issuance in
connection with the Rights Agreement hereinafter described. See "Approval of
Amendment to the Company's Restated Certificate of Incorporation to Increase the
Number of Authorized Shares of Common Stock - Purpose and Effect of the Proposed
Amendment" on page 11.
10
<PAGE> 13
PROPOSED AMENDMENT TO RESTATED CERTIFICATE OF INCORPORATION
The proposed amendment to the Restated Certificate of Incorporation
will be effected by amending and restating in its entirety the first sentence of
Article Fourth of the Restated Certificate of Incorporation to provide as
follows:
This Corporation shall be authorized to issue Fifty-one Million
(51,000,000) shares of capital stock, which shall be divided into Fifty
Million (50,000,000) shares of Common Stock, with a par value of one
cent ($.01) per share, and One Million (1,000,000) shares of Preferred
Stock, with a par value of one cent ($.01) per share.
PURPOSE AND EFFECT OF THE PROPOSED AMENDMENT
The Board of Directors believes that it is in the Company's best
interest to increase the number of authorized but unissued shares of Common
Stock in order to have additional shares available for issuance to meet the
Company's future business needs as they arise. The Board believes the
availability of the additional shares will provide the Company with the
flexibility to issue Common Stock for a variety of proper corporate purposes as
the Board of Directors may deem advisable without further action by the
Company's shareholders, except as may be required by law or by regulation or
rule of The Nasdaq Stock Market. These purposes could include, among others, the
sale of stock to obtain additional capital funds, the purchase of property, the
acquisition by merger into the Company or otherwise of other companies, use in
various equity compensation and other employee benefit plans, the declaration of
stock dividends or distributions and other bona fide corporate purposes. The
Company's management has no present arrangements, agreements, understandings or
plans for the issuance or use of the additional shares proposed to be authorized
by the Amendment, other than as stated in the proposal to amend and restate the
Company's 1996 Equity Compensation Plan to increase the number of shares
authorized to be issued thereunder from 450,000 to 600,000 shares.
Under the Restated Certificate of Incorporation, the Company's
shareholders do not have preemptive rights with respect to Common Stock. Thus,
should the Board of Directors elect to issue additional shares of Common Stock,
shareholders would not have preferential rights to purchase such shares. In
addition, if the Board of Directors elects to issue additional shares of Common
Stock, such issuance could have a dilutive effect on earnings per share and on
the voting power and shareholdings of then current shareholders.
Although an increase in the authorized shares of Common Stock could,
under certain circumstances, also be construed as having an anti-takeover
effect, the current proposal to amend the Restated Certificate of Incorporation
is not in response to any effort to accumulate the Company's stock or to obtain
control of the Company. In addition, the proposal is not part of any plan by
management to recommend a series of similar amendments to the Board of Directors
and the shareholders. The Board also does not currently contemplate recommending
the adoption of any other amendments to the Restated Certificate of
Incorporation which could be construed to affect the ability of third parties to
take over or change control of the Company.
Although, as stated above, the purpose of seeking an increase in the
number of authorized shares of Common Stock is not intended for anti-takeover
purposes, Securities and Exchange Commission rules require disclosure of
charter, by-law and other provisions that could have an anti-takeover effect. In
the Company's case, these include: (i) a shareholder rights plan under the
Rights Agreement, dated as of October 3, 1991 (the "Rights Agreement"), between
the Company and American Stock Transfer & Trust Company (as successor to First
Interstate Bank of Arizona, N.A.), as Rights Agent, also commonly known as a
"poison pill;" (ii) Board authority under the Restated Certificate of
Incorporation to issue one or more series of preferred stock up to a maximum of
1,000,000 shares, of which 50,000 shares were designated Series A Junior
Participating Preferred Shares, $.01 par value, in connection with the Rights
Agreement; (iii) a classified board of directors with staggered four-year terms
of office; and (iv) the requirement for the approval of not less than 80% of the
outstanding shares of voting stock of the Company in connection with certain
Business Combinations with any Related Person as specified in the
11
<PAGE> 14
Restated Certificate of Incorporation, each of which could have a deterrent
effect against a takeover of the Company.
The Rights Agreement provides that each share of the Company's Common
Stock outstanding as of October 14, 1991 has associated with it one right to
purchase one one-hundredth of a share of the Series A Junior Participating
Preferred Shares at an exercise price, subject to adjustment, of $40 per share.
The rights will be exercisable only if a person or group obtains the right to
acquire beneficial ownership of 20% or more of the outstanding Common Stock of
the Company, or after the commencement of a tender offer or an exchange offer
that would result in a person or group beneficially owning 20% or more of the
outstanding Common Stock. If anyone acquires 20% or more of the Company's
outstanding Common Stock, the rights would entitle shareholders (other than the
20% acquiror) to purchase for $40 the number of shares of the Company's Common
Stock which would have a market value of $80. In the event that the Company is
acquired in a merger or other business combination, the rights would entitle the
shareholders (other than the acquiror) to purchase securities of the surviving
company at a similar discount. In lieu of requiring payment of the exercise
price of the rights upon the occurrence of the above-noted events, the Company
may permit the holders to simply surrender the rights and receive the number of
shares of the Company's Common Stock which would have a market value of $40. The
Rights Agreement expires on October 14, 2001.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR THE PROPOSAL
TO AMEND THE RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF
AUTHORIZED SHARES OF COMMON STOCK FROM FIFTEEN MILLION (15,000,000) TO FIFTY
MILLION (50,000,000).
EXECUTIVE COMPENSATION
COMPENSATION
The following table sets forth certain information with respect to
compensation earned during fiscal years 1997, 1996 and 1995 by the Company's
chief executive officer and the Company's other executive officers whose salary
and bonus from the Company or any subsidiary exceeded $100,000 in fiscal year
1997 (the "Named Executive Officers").
12
<PAGE> 15
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
Long-Term
Compensation
Awards
Annual Compensation --------------
--------------------------------------- Securities
Name and Other Annual Underlying All Other
Principal Position Year Salary Bonus Compensation(1) Options/SARs(#) Compensation(2)
------------------ ---- ------ ----- --------------- --------------- ---------------
<S> <C> <C> <C> <C> <C> <C>
Leo C. Beebe(3) ............ 1997 $275,000 $225,000 $ 0 -0- $ 18,138
Chief Executive Officer 1996 200,000 100,000 0 -0- 19,938
and Chairman of the Board 1995 33,000 0 4,866 -0- 11,081
of Directors
Robert L. Weinberg ......... 1997 $160,500 $ 58,833 $ 1,577(4) -0- $ 21,957
Senior Executive Vice 1996 150,000 37,500 1,010(4) -0- 19,049
President, Chief Financial 1995 129,962 0 1,010(4) 8,500 25,247
Officer and Treasurer
Kevin C. Bowen(5) .......... 1997 $137,825 $ 50,521 $ 342(4) -0- $ 16,473
President and Chief 1996 128,800 32,200 201(4) -0- 13,023
Executive Officer of
K-Tron America, Inc.
Lukas Gunthardt(5) ......... 1997 $127,209(6) $ 50,521 $ 0 -0- $ 16,314
Managing Director and 1996 139,760(6) 34,940 0 -0- 19,165
Chief Executive Officer of
K-Tron (Switzerland) Ltd.
</TABLE>
- ----------
(1) In fiscal years 1997, 1996 and 1995, no Named Executive Officer, other
than Mr. Beebe with respect to fiscal year 1995, received perquisites or
other personal benefits, securities or property which exceeded the lesser
of $50,000 or 10% of such executive officer's salary and bonus. In fiscal
year 1995, Mr. Beebe received reimbursement of $1,750 in connection with
the preparation of annual tax returns and was paid $3,116 as an automobile
allowance.
(2) The amounts disclosed in this column include:
(a) Company and subsidiary contributions under the thrift portion of
Company's 401(k) Profit-Sharing and Thrift Plan on behalf of the following
Named Executive Officers: For fiscal year 1997 - Mr. Beebe $9,500, Mr.
Weinberg $9,500 and Mr. Bowen $9,500. For fiscal year 1996 - Mr. Beebe
$9,000, Mr. Weinberg $9,000 and Mr. Bowen $7,709. For fiscal year 1995 -
Mr. Beebe $2,000 and Mr. Weinberg $7,798. No contributions were made under
the profit-sharing portion of the plan.
(b) Company and subsidiary payments for supplemental health insurance on
behalf of the following Named Executive Officers: For fiscal year 1997 -
Mr. Beebe $3,649, Mr. Weinberg $3,594 and Mr. Bowen $5,432. For fiscal
year 1996 - Mr. Beebe $6,241, Mr. Weinberg $2,446 and Mr. Bowen $4,906.
For fiscal year 1995 - Mr. Beebe $4,384 and Mr. Weinberg $9,846.
(c) Company and subsidiary payments of premiums for additional group term
life insurance on behalf of the following Named Executive Officers: For
fiscal year 1997 - Mr. Beebe $4,989, Mr. Weinberg $3,510 and Mr.
13
<PAGE> 16
Bowen $696. For fiscal year 1996 - Mr. Beebe $4,697, Mr. Weinberg $2,250
and Mr. Bowen $408. For fiscal year 1995 - Mr. Beebe $4,697 and Mr.
Weinberg $2,250.
(d) Company and subsidiary payments of premiums for additional term life
insurance on behalf of the following Named Executive Officers: For fiscal
year 1997 - Mr. Weinberg $2,168 and Mr. Bowen $845. For fiscal year 1996 -
Mr. Weinberg $2,168. For fiscal year 1995 - Mr. Weinberg $2,168.
(e) Company payment in fiscal years 1997, 1996 and 1995 of premiums for
additional disability insurance on behalf of Mr. Weinberg: $3,185 in each
year.
(f) Subsidiary contribution in fiscal years 1997 and 1996 in U.S. dollars
(based on the average $/Sfr. exchange rates for 1997 of $.689 and 1996 of
$.810) to the Swiss pension plan on behalf of Mr. Gunthardt: $16,314 and
$19,165, respectively.
(3) Mr. Beebe became Chief Executive Officer of the Company on June 30, 1995,
a position which he had previously held from July 1985 until August 1992.
On February 3, 1995, Mr. Beebe assumed active responsibility for the
Company's operations other than a German subsidiary which was sold in June
1995, and he voluntarily reduced his salary from $200,000 to $1 per year,
effective March 1, 1995. While serving for this nominal salary, Mr. Beebe
continued to receive his health and life insurance and other benefits.
Effective January 1, 1996, Mr. Beebe's salary was restored to $200,000 per
year. On January 5, 1998, Mr. Beebe retired as Chief Executive Officer and
Chairman of the Board of Directors of the Company.
(4) Represents amounts reimbursed to certain of the Named Executive Officers
for estimated income taxes incurred with respect to additional group term
life insurance purchased on their behalf.
(5) Messrs. Gunthardt and Bowen became executive officers of the Company in
1996; therefore, their compensation for 1995 is not required to be
disclosed.
(6) Mr. Gunthardt's 1997 and 1996 salary, bonus and other compensation were
paid in Swiss francs, and the salary, bonus and other compensation amounts
included in the table are expressed in U.S. dollars using the average
$/Sfr. exchange rates for 1997 of $.689 and 1996 of $.810. Mr. Gunthardt's
salary in Swiss francs was Sfr. 184,575 in 1997 and Sfr. 172,500 in 1996.
On January 5, 1998, Edward B. Cloues, II became Chairman of the Board of
Directors and Chief Executive Officer of the Company. For information relating
to Mr. Cloues' employment with the Company, see "Executive Compensation - Option
Grants" below and "Executive Compensation - Certain Employment Agreements" on
page 15.
OPTION GRANTS
No Named Executive Officer received an option grant during fiscal year
1997. However, on October 6, 1997, the effective date of the employment
agreement between the Company and Edward B. Cloues, II, Mr. Cloues received two
stock option grants to purchase an aggregate of 100,000 shares of Common Stock
at an exercise price of $14.00 per share. Specifically, Mr. Cloues was granted a
nonqualified stock option to purchase 64,290 shares of Common Stock that vests
in three equal installments of 21,430 shares each on January 5, 1998, 1999 and
2000 and an incentive stock option to purchase 35,710 shares of Common Stock
that vests in five equal installments of 7,142 shares each on October 6, 1997,
January 5, 1998, January 5, 1999, January 5, 2000, and January 4, 2001.
14
<PAGE> 17
OPTION EXERCISES AND FISCAL YEAR-END VALUES
The following table sets forth certain information regarding the number
and value of stock options held at January 3, 1998 by the Named Executive
Officers.
AGGREGATE OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END OPTION
VALUES
<TABLE>
<CAPTION>
NUMBER OF VALUE OF
UNEXERCISED UNEXERCISED IN-THE-
OPTIONS AT MONEY OPTIONS AT
JANUARY 3, 1998 JANUARY 3, 1998(1)
--------------------------- ---------------------------
SHARES ACQUIRED VALUE
NAME ON EXERCISE REALIZED EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
- ---- ----------- -------- ----------- ------------- ----------- -------------
<S> <C> <C> <C> <C> <C> <C>
Leo C. Beebe -- -- 7,000 0 $ 56,000 --
Robert L. Weinberg -- -- 20,500 9,500 158,812 $ 75,812
Kevin C. Bowen 1,000 $7,500 10,250 4,250 92,250 40,750
Lukas Gunthardt -- -- 6,500 6,500 58,687 58,687
</TABLE>
- ----------
(1) Based on the closing price of the Company's Common Stock as reported on
the National Market segment of The Nasdaq Stock Market on January 2, 1998
($17.25 per share), net of the option exercise price.
CERTAIN EMPLOYMENT AGREEMENTS
Messrs. Weinberg, Bowen and Gunthardt were employed by the Company
during fiscal year 1997 under employment agreements with the Company (the
"Employment Agreements"). Under these Employment Agreements, Messrs. Weinberg,
Bowen and Gunthardt are entitled to receive a base salary, which may be
increased from time to time, and such additional compensation and bonus payments
as may be awarded to them. During fiscal year 1997, the base salaries for
Messrs. Weinberg, Bowen and Gunthardt were $160,500, $137,825 and Sfr. 184,575
(the equivalent of $127,209 based on the average $/Sfr. exchange rate for 1997),
respectively. As of January 1, 1998, Mr. Weinberg's base salary was increased to
$170,000, Mr. Bowen's to $150,000 and Mr. Gunthardt's to Sfr. 211,707 (the
equivalent of approximately $150,000 based on the $/Sfr. exchange rate used at
the time the salary increase was determined). The Company's obligation to pay
such base salaries is subject to the Company's right to reduce them in the event
reductions are generally being made for other officers of the Company or its
subsidiaries holding comparable positions.
Each of the Employment Agreements provides that either the Company or
the employee may terminate the employment term thereunder upon not less than one
years prior notice. Such employment terms are also subject to termination by
reason of the employee's death or disability or by the Board of Directors at any
time for "cause" as specified in the Employment Agreements. In addition, the
Company has the right to terminate Mr. Weinberg, Mr. Bowen or Mr. Gunthardt at
any time without cause by paying him a lump sum amount equal to 100% of his
then-annual base salary or, if the previously described one-year notice of
termination has already been given by the Company to him, the portion thereof
relating to the balance of the employment term.
On October 6, 1997, the Company entered into an employment agreement
with Mr. Cloues pursuant to which he will serve as the Company's Chairman of the
Board of Directors and Chief Executive Officer. Under his employment agreement,
during fiscal year 1997 Mr. Cloues received $30,000 and a stock grant for 10,000
shares of unregistered Common Stock. Commencing in fiscal year 1998, Mr. Cloues
will be entitled to receive a base salary of $380,000, which may be increased
from time to time, and bonus payments at the sole discretion of the Board or
authorized Committee thereof. In addition, in fiscal year 1998, Mr. Cloues will
be entitled to receive a restricted stock grant for 20,000 shares of registered
Common Stock.
15
<PAGE> 18
Mr. Cloues' employment agreement provides that he can terminate the
agreement upon not less than 90 days prior notice. The agreement also provides
that the Company may terminate Mr. Cloues without cause at any time after
January 8, 2001; provided, that prior to January 8, 2001 the Company must
provide Mr. Cloues with not less than two years prior notice of termination. At
Mr. Cloues' election, he may then terminate the relationship. After January 8,
2001, the Company may terminate Mr. Cloues without cause with not less than 30
days prior written notice. In either case, in the event of a termination without
cause, Mr. Cloues would be entitled to a lump sum payment equal to 200% of his
then-annual base salary. Mr. Cloues' employment term is also subject to
termination by reason of his death or disability or by the Board of Directors at
any time for "cause" as specified in his employment agreement.
In addition, Mr. Cloues' employment agreement includes provisions
relating to a termination of employment upon a "change of control" (as specified
in his employment agreement). Mr. Cloues' employment agreement applies to a
termination of employment upon or within one year after a "change in control"
which, if such termination was initiated by the Company or any successor
thereto, was for any reason other than death, disability or "cause" or which, if
such termination was initiated by Mr. Cloues, was at his sole discretion without
regard to reason. In the event of the termination of employment of Mr. Cloues
upon a "change of control," his employment agreement provides that, subject to
certain limitations, the Company would pay him (i) an amount equal to three
times his annual base salary in effect either immediately prior to the
termination of employment or immediately prior to the "change of control,"
whichever is higher and (ii) unless Mr. Cloues notifies the Company in writing
that he intends to retain his options, an amount equal to the spread (the excess
of market value over exercise price) on any stock options held by him, whether
or not such options were exercisable at the date of termination.
NOTWITHSTANDING ANYTHING TO THE CONTRARY, THE FOLLOWING REPORT OF THE
COMPENSATION AND HUMAN RESOURCES COMMITTEE AND THE PERFORMANCE GRAPH ON
PAGE 19 SHALL NOT BE DEEMED INCORPORATED BY REFERENCE BY ANY GENERAL
STATEMENT INCORPORATING BY REFERENCE THIS PROXY STATEMENT INTO ANY
FILING UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, EXCEPT TO THE EXTENT THAT
THE COMPANY SPECIFICALLY INCORPORATES THIS INFORMATION BY REFERENCE,
AND SHALL NOT OTHERWISE BE DEEMED FILED UNDER SUCH ACTS.
REPORT OF THE COMPENSATION
AND HUMAN RESOURCES COMMITTEE
As members of the Compensation and Human Resources Committee (the
"Compensation Committee"), it is our duty to review the compensation of all
executive officers of the Company, to recommend to the Board the base salary of
the Company's Chief Executive Officer, to approve the base salaries of all other
executive officers and to approve all bonuses and other material compensation
granted to executive officers, including the Chief Executive Officer. In
addition, we also constitute the committee which administers the Company's 1996
Equity Compensation Plan and thus are responsible for the granting of stock
options, stock appreciation rights and restricted stock to executive officers.
These duties and the other responsibilities of the Compensation Committee are
more fully described on page 6 of this Proxy Statement under the caption
"Matters Concerning Directors Committees and Meetings." In fulfilling these
duties and responsibilities, it is the Compensation Committee's goal to have a
policy that will enable the Company to attract, retain and reward executive
officers who contribute to both its short-term and long-term success. The
members of the Compensation Committee are all non-employee, independent
directors.
The Company's compensation policy for executive officers is to pay
competitively and to be fair and equitable in the administration of pay. This is
the same policy applicable to all employees of the Company. The Company seeks to
balance the compensation paid to a particular individual with the compensation
paid to other executives holding comparable positions both inside the Company
and at other similar companies.
16
<PAGE> 19
For fiscal year 1997, the Compensation Committee recommended and the
Board approved an incentive compensation program consisting of two parts, one
involving cash payments and the other the grant of stock options. Under this
program, no incentive compensation was earned until the Company's pre-tax budget
was met; then, the incentive compensation pool filled until it equaled 20% of
pre-tax, pre-incentive compensation income. The amount payable continued to grow
after the pre-tax budget had been met and the 20% incentive compensation pool
filled, with such growth equaling 20% of all additional pre-tax, pre-incentive
compensation income. The total incentive compensation pool was then split
approximately 50/50 between an identified group of managers and all other
employees, with specific awards dependent on both overall corporate and local
performance. All incentive compensation awards were paid in cash, and each
manager's award was based on the Chief Executive Officer's judgment, which
included consideration of pre-tax profit, return on net assets and growth
strategy implementation. The amount of the incentive compensation award to the
Chief Executive Officer during fiscal year 1997 was determined by the
Compensation Committee. With respect to stock options, up to 50,000 were
eligible to be granted under the program as a result of the Company achieving
its objective of 15% earnings per share growth in fiscal year 1997. The members
of the Compensation Committee, acting as the Stock Option Committee as
hereinafter defined, approved grants of options to purchase 49,000 shares of
Common Stock, and all such grants were at market price on the grant date and
vest over three years from that date.
Since the Company achieved its fiscal year 1997 pre-tax budget, bonuses
were paid under the program, including a $225,000 bonus to Leo C. Beebe, the
Company's Chief Executive Officer who retired January 4, 1998. Mr. Beebe's bonus
was determined by the Compensation Committee and reflected the Compensation
Committee's recognition of the key role played by Mr. Beebe in the Company's
increased profitability during fiscal year 1997 and of his longstanding service
to the Company. The Compensation Committee also considered the fact that Mr.
Beebe would not receive a stock option grant because of his retirement. The
awards made to the other three executive officers of the Company were
recommended by Mr. Beebe and approved by the Compensation Committee, and they
equaled approximately 36.5% of each of their base salaries, or a total of
$159,875. In addition, the other three executive officers each received a stock
option grant to purchase 5,000 shares of Common Stock at an exercise price of
$16.38 per share.
For fiscal year 1998, the Compensation Committee has recommended and
the Board has approved an incentive compensation program that is substantially
similar to last year's program with two changes. First with respect to the
calculation of the incentive compensation pool, the Board and the Chief
Executive Officer will have the authority to remove significant extraordinary
items from the calculation, and second, the stock options that may be granted
under the program will vest over four years instead of three.
With respect to salaries, bonuses and other compensation, the decisions
of the Compensation Committee are subjective and are not based on any list of
specific criteria. We believe that the compensation received by each of the
executive officers for fiscal year 1997 was reasonable in view of their
contributions to the Company during the year. The Company's Chief Executive
Officer, Leo C. Beebe, had a 1997 base salary of $275,000 which was still
$25,000 below the base salary of $300,000 which he was receiving when he first
retired as the Company's Chief Executive Officer in mid-1992. With respect to
the Company's other executive officers, their base annual salaries during fiscal
year 1997 were as follows: Mr. Weinberg, $160,500; Mr. Bowen, $137,825; and Mr.
Gunthardt, 184,575 Sfr. ($127,209 at the average $/Sfr. exchange rate for 1997).
Effective at the beginning of fiscal year 1998, these base annual salaries were
increased to $170,000, $150,000 and 211,707 Sfr., respectively. These raises
were recommended by the Chief Executive Officer and approved by the Compensation
Committee. All three of these executive officers made substantial contributions
to the Company's increased profitability during both 1997 and 1996.
In addition, during fiscal 1997 the Compensation Committee approved an
employment agreement with Edward B. Cloues, II containing terms recommended by
the Compensation Committee to the Board and approved by the Board. Mr. Cloues, a
director of the Company since July 1985, became the Company's Chairman of the
Board and Chief Executive Officer on January 5, 1998. Under his employment
agreement, during fiscal year 1997 Mr. Cloues received $30,000 and a stock grant
for 10,000 shares of unregistered Common Stock. Commencing in
17
<PAGE> 20
fiscal year 1998, Mr. Cloues will be entitled to receive a base salary of
$380,000, which may be increased from time to time, and bonus payments at the
sole discretion of the Board or the Compensation Committee.
As stated above, the members of the Compensation Committee also serve
as the members of the committee (the "Stock Option Committee") which administers
the 1996 Equity Compensation Plan which provides for grants of stock options,
stock appreciation rights and restricted stock. The purpose of stock option
grants is to provide an additional incentive to key employees to work to
maximize shareholder value, and vesting periods may be utilized to encourage
such employees to remain with the Company. Stock option grants are entirely at
the discretion of the Stock Option Committee, including their timing, the
recipients thereof and the number of shares underlying any particular grant.
Under the terms of his employment agreement, Mr. Cloues received two stock
option grants for an aggregate of 100,000 shares of Common Stock under the 1996
Equity Compensation Plan during fiscal year 1997. No other options were granted
under the 1996 Equity Compensation Plan during fiscal year 1997; however, stock
options for an aggregate of 49,000 were granted in the beginning of fiscal year
1998 pursuant to the Company's incentive compensation program described above.
Further, in addition to the 10,000 shares granted to Mr. Cloues referred to in
the preceding paragraph, Mr. Cloues' employment agreement provides that he will
receive on October 7, 1998 a restricted stock grant for 20,000 shares of
registered Common Stock under the 1996 Equity Compensation Plan. Such grant
shall provide that the restriction shall lapse as to 10,000 of such shares on
January 5, 1999 and as to the other 10,000 shares on January 5, 2000.
Payments during 1997 to the Company's executives as discussed above
were made with regard to the provisions of Section 162(m) of the Internal
Revenue Code. Section 162(m) limits the deduction that may be claimed by a
"public company" for compensation paid to certain individuals to $1 million
except to the extent that any excess compensation is "performance-based
compensation." It is the Compensation Committee's intention that no compensation
will be limited as to its deductibility under Section 162(m).
COMPENSATION AND HUMAN RESOURCES COMMITTEE
Norman Cohen, Chairman
Richard J. Pinola
Jean Head Sisco
March 13, 1998
18
<PAGE> 21
PERFORMANCE GRAPH
The following line graph compares the yearly percentage change in the
cumulative total shareholder return on the Company's Common Stock for the past
five fiscal years with the cumulative total return of the Standard & Poor's 500
Stock Index (the "S&P 500") and the Dow Jones Factory Equipment Industry Group,
described more fully below (the "Factory Equipment Group"). Dividend
reinvestment has been assumed and, with respect to companies in the Factory
Equipment Group, the returns of each such company have been weighted at each
measurement point to reflect relative stock market capitalization.
[LINE CHART]
<TABLE>
<CAPTION>
1992 1993 1994 1995 1996 1997
<S> <C> <C> <C> <C> <C> <C>
K-Tron International, Inc. $100.00 $ 80.39 $ 84.31 $ 49.02 $ 80.39 $135.29
S&P 500 Index $100.00 $110.08 $111.54 $153.45 $188.69 $251.64
Factory Equipment Group $100.00 $118.46 $119.75 $155.40 $161.08 $186.66
</TABLE>
The Factory Equipment Group is not a "published industry or
line-of-business index" as that term is defined by Securities and Exchange
Commission regulations. Accordingly, the Factory Equipment Group is considered a
"peer index," and the identity of the issuers used in the index is as follows:
American Vanguard Corp., Baldwin Technology Inc. Class A, Bethlehem Corporation,
Binks Sames Corp., Bridgeport Machines Inc., Brown & Sharpe Manufacturing Co.
Class A, Calnetics Corporation, Chicago Rivet & Machine Co., Cincinnati Milacron
Inc., Devlieg-Bullard Inc., Farrel Corporation, Flow International Corp.,
Gardner Denver Machinery, Inc., Gleason Corporation, The Gorman-Rupp Company,
Hirsch International Corp. Class A, Hurco Companies Inc., Impact Systems, Inc.,
Innovex Inc., Inotek Technologies Corp., Interlake Corp., Invivo Corporation,
K-Tron International, Inc., Katy Industries, Inc., Key Technology Inc., Kulicke
& Soffa Industries, Inc., Lynch Corporation, McClain Industries, Inc., Middleby
Corporation, The Monarch Machine Tool Co. & Subsidiaries, Moore Products Co.,
Paul Mueller Company, Nordson Corporation, Oilgear Company, Orbotech Ltd.,
Princeton Media Group Inc., Quipp, Inc., Regal-Beloit Corp, Secom General
Corporation, Selas Corporation of America, Shelter Components Corporation, SI
Handling Systems, Inc., Sonics & Materials, Inc., Speizman Industries Inc., The
L.S. Starrett Company, Summa Industries, Taylor Devices, Inc., Thermo Terratech,
Inc., Twin Disc Incorporated, Unit Instruments Inc. (CA), Utilx Corporation and
Valmet Oy Ads.
19
<PAGE> 22
INDEPENDENT PUBLIC ACCOUNTANTS
Arthur Andersen LLP has served as the Company's independent public
accountants and auditors since 1994. Arthur Andersen LLP has been selected to
continue in such capacity for the current year. A representative of that firm is
expected to be present at the Annual Meeting with the opportunity to make a
statement if he or she desires to do so and to be available to respond to
appropriate questions.
SHAREHOLDER PROPOSALS -- 1999 ANNUAL MEETING
Shareholders may submit proposals on matters appropriate for
shareholder action at annual meetings in accordance with regulations adopted by
the Securities and Exchange Commission. Any proposal which an eligible
shareholder desires to have presented at the 1999 annual meeting of shareholders
(which is expected to be held on or about May 7, 1999) concerning a proper
subject for inclusion in the proxy statement and for consideration at the annual
meeting, will be included in the Company's proxy statement and related proxy
card if it is received by the Company no later than November 19, 1998.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934, as amended,
requires that directors and certain officers of the Company, and persons who own
more than ten percent of the Company's Common Stock, file with the Securities
and Exchange Commission initial reports of ownership and reports of changes in
ownership of such Common Stock. Such directors, officers and more than ten
percent shareholders are required by regulation to furnish the Company with
copies of all Section 16(a) forms which they file.
To the Company's knowledge, based solely on a review of the copies of
such reports furnished to the Company and written representations that no other
reports were required, all fiscal year 1997 Section 16(a) filing requirements
applicable to its directors, officers and more than ten percent shareholders
were complied with. In addition, while an annual statement on Form 5 under
Section 16(a) is not required to be filed if there are no previously unreported
transactions or holdings to report, nevertheless the Company is obligated to
disclose the names of directors, covered officers and more than ten percent
shareholders who did not file an annual statement on Form 5 unless the Company
received a written statement that no such filing was required. As of March 18,
1998, the Company had not received either an annual statement on Form 5 for
fiscal year 1997 or such a written statement from the Estate of Dr. Mario Gallo,
a more than ten percent shareholder.
OTHER MATTERS
The Board of Directors of the Company does not intend to bring any
other matters before the Annual Meeting and has no reason to believe any other
matters will be presented. If, however, other matters properly do come before
the meeting, it is the intention of the persons named as proxy agents in the
enclosed Proxy Card to vote upon such matters in accordance with their judgment.
By Order of the Board of Directors,
Mary E. Vaccara
Assistant Secretary
March 23, 1998
20
<PAGE> 23
EXHIBIT A
AMENDED AND RESTATED
K-TRON INTERNATIONAL, INC.
1996 EQUITY COMPENSATION PLAN
(March 13, 1998)
The purpose of the K-Tron International, Inc. 1996 Equity Compensation
Plan (the "Plan") is (i) to provide officers and other employees of K-Tron
International, Inc. (the "Company") and its subsidiaries with the opportunity to
receive grants of incentive stock options, nonqualified stock options, stock
appreciation rights and restricted stock and (ii) to provide members of the
Board of Directors of the Company (the "Board") who are not employees of the
Company and its subsidiaries ("Non-Employee Directors") with the opportunity to
receive grants of nonqualified stock options. The Company believes that the Plan
will provide an incentive to the participants to contribute materially to the
long-term growth of the Company, will align the economic interests of the
participants with those of the Company's shareholders and will aid the Company
and its subsidiaries in attracting and retaining officers, employees and Board
members of outstanding ability.
1. Administration
The Plan shall be administered and interpreted by a committee (the
"Committee"), which shall consist of two or more persons appointed by the Board,
all of whom may be "non-employee directors" as defined in Rule 16b-3 under the
Securities Exchange Act of 1934 (the "Exchange Act") and "outside directors" as
defined in Section 162(m) of the Internal Revenue Code of 1986, as amended (the
"Code"), and related Treasury regulations.
The Committee shall have the sole authority to (i) determine the
individuals to whom grants shall be made under the Plan, (ii) determine the
type, size and terms of the grants to be made to each such individual, (iii)
determine the time when the grants will be made and the duration of any
applicable exercise or restriction period, including the criteria for vesting
and the acceleration of vesting and (iv) deal with any other matters arising
under the Plan.
The Committee shall have full power and authority to administer and
interpret the Plan, to make factual determinations and to adopt or amend such
rules, regulations, agreements and instruments for implementing the Plan and for
the conduct of its business as it deems necessary or advisable, in its sole
discretion. The Committee's interpretations of the Plan and all determinations
made by the Committee pursuant to the powers vested in it hereunder shall be
conclusive and binding on all persons having any interests in the Plan or in any
awards granted hereunder. All powers of the Committee shall be executed in its
sole discretion, in the best interest of the Company and in keeping with the
objectives of the Plan and need not be uniform as to similarly situated
individuals.
2. Grants
Incentives under the Plan shall consist of incentive stock options,
nonqualified stock options, stock appreciation rights and restricted stock
(hereinafter collectively referred to as "Grants"). All Grants shall be subject
to the terms and conditions set forth herein and to those other terms and
conditions consistent with the Plan as the Committee deems appropriate and as
are specified in writing by the Committee to the individual in a grant letter
(the "Grant Letter") or an amendment thereto. The Committee shall approve the
form and provisions of each Grant Letter or amendment. Grants under a particular
Section of the Plan need not be uniform as among the grantees.
3. Shares Subject to the Plan
(a) Subject to the adjustments specified in Section 3(b), the aggregate
number of shares of common stock of the Company (the "Company Stock") that may
be issued or transferred pursuant to Grants or otherwise under the Plan is
600,000 shares. Notwithstanding anything in the Plan to the contrary, the
maximum aggregate
<PAGE> 24
number of shares of Company Stock that shall be subject to Grants made under the
Plan to any single employee during any one year period shall be 100,000 shares.
The shares may be authorized but unissued shares of Company Stock or reacquired
shares of Company Stock, including shares purchased by the Company on the open
market for purposes of the Plan. If and to the extent options granted under the
Plan terminate, expire or are canceled, forfeited, exchanged or surrendered
without having been exercised, or if any shares of restricted stock are
forfeited, the shares subject to such Grants shall again be available for
purposes of the Plan.
(b) If there is any change in the number or kind of shares of Company
Stock outstanding by reason of (i) a stock dividend, (ii) a recapitalization,
(iii) a stock split, combination or exchange of shares, (iv) a merger,
reorganization or consolidation in which the Company is the surviving
corporation, (v) a reclassification or (vi) any other extraordinary or unusual
event affecting the outstanding Company Stock as a class without in any of such
cases the Company's receipt of consideration, or if in the opinion of the
Committee the value of outstanding shares of Company Stock is substantially
reduced due to the Company's payment of an extraordinary dividend or
distribution, the maximum number of shares of Company Stock available for
Grants, the maximum number of shares of Company Stock which any one individual
participating in the Plan may be granted during any one year, the number of
shares covered by outstanding Grants and the price per share or the applicable
market value of such Grants shall be proportionately adjusted by the Committee
to reflect any increase or decrease in the number or kind of issued shares of
Company Stock to preclude the enlargement or dilution of rights and benefits
under such Grants; provided, however, that any fractional shares resulting from
such adjustment shall be eliminated. The adjustments determined by the Committee
shall be final, binding and conclusive. Notwithstanding the foregoing, no
adjustment shall be authorized or made pursuant to this Section if such
authorization or adjustment would cause any Incentive Stock Option to fail to
comply with Section 422 of the Code.
4. Eligibility for Participation
All employees employed by the Company or any subsidiary ("Employees")
(including Employees who are officers or members of the Board) shall be eligible
to participate in the Plan. The Committee shall select the Employees to receive
Grants and determine the number of shares of Company Stock subject to a
particular Grant in such manner as the Committee determines. Non-Employee
Directors shall be eligible to receive options pursuant to Section 5(i) of the
Plan. Employees and Non-Employee Directors who receive Grants under this Plan
shall hereinafter be referred to as "Grantees". The term "Company" as used
hereinafter when referring to Grantees or matters involving Grantees (such as
termination of employment or the withholding of taxes) shall include the
Company's subsidiaries.
Nothing contained in this Plan shall be construed to limit the right of
the Company to make Grants in connection with the acquisition, by purchase,
lease, merger, consolidation or otherwise, of the business or assets of any
corporation, firm or association, including options granted to employees or
directors thereof who become Employees or Non-Employee Directors of the Company,
or for any other proper corporate purpose.
5. Granting of Stock Options
(a) Number of Shares. The Committee, in its sole discretion, shall
determine the number of shares of Company Stock that will be subject to each
Grant of stock options.
(b) Type of Option and Price. The Committee may grant options intended
to qualify as incentive stock options ("Incentive Stock Options") within the
meaning of Section 422 of the Code or options which are not intended so to
qualify ("Nonqualified Stock Options") (hereinafter collectively referred to as
"Stock Options") or any combination of Incentive Stock Options and Nonqualified
Stock Options, all in accordance with the terms and conditions set forth herein.
Incentive Stock Options may only be granted to Employees.
The per share purchase price of Company Stock subject to a Stock Option
shall be determined by the Committee and may be equal to, greater than or less
than the Fair Market Value (as defined in the next paragraph)
2
<PAGE> 25
of a share of such Stock on the date such Stock Option is granted; provided,
however, that (i) the per share purchase price of Company Stock subject to an
Incentive Stock Option shall be equal to, or greater than, the Fair Market Value
of a share of such Stock on the date such Stock Option is granted and (ii) an
Incentive Stock Option may not be granted to an Employee who, at the time of
grant, owns stock possessing more than ten percent (10%) of the total combined
voting power of all classes of stock of the Company, or any parent or subsidiary
of the Company, unless the purchase price per share is not less than one hundred
ten percent (110%) of the Fair Market Value of a share of such Stock on the date
of grant.
If the Company Stock is traded in a public market, then the Fair Market
Value per share shall be determined as follows: (i) if the principal trading
market for the Company Stock is a national securities exchange or the National
Market segment of The Nasdaq Stock Market, the last reported sale price thereof
on the relevant date or, if there were no trades on that date, the latest
preceding date upon which a sale was reported, or (ii) if the Company Stock is
not principally traded on any such exchange or market, the mean between the last
reported "bid" and "asked" prices thereof on the relevant date, as reported on
Nasdaq or, if not so reported, as reported by the National Daily Quotation
Bureau, Inc. or as reported in a customary financial reporting service, as
applicable and as the Committee determines. If the Company Stock is not traded
in a public market or subject to reported transactions or "bid" and "asked"
quotations as set forth above, the Fair Market Value per share shall be as
determined by the Committee.
(c) Exercise Period. The Committee shall determine the exercise period
of each Stock Option. The exercise period shall not exceed ten (10) years from
the date of grant. However, an Incentive Stock Option that is granted to an
Employee who, at the time of grant, owns stock possessing more than ten percent
(10%) of the total combined voting power of all classes of stock of the Company,
or any parent or subsidiary of the Company, may not have a term that exceeds
five (5) years from the date of grant.
(d) Vesting and Exercisability of Options. Stock Options shall become
vested and exercisable in accordance with the terms and conditions determined by
the Committee, in its sole discretion and as specified in the applicable Grant
Letter. The Committee, in its sole discretion, may accelerate the exercisability
of any or all outstanding Stock Options at any time for any reason. In addition,
all outstanding Stock Options shall vest upon a Change of Control (as defined in
Section 9) unless the Committee determines otherwise pursuant to Section 10.
(e) Manner of Exercise. A Grantee may exercise a Stock Option which has
become exercisable, in whole or in part, by delivering a written notice of
exercise to the Committee or other recipient designated by the Committee for
this purpose, with accompanying payment of the option price in accordance with
Section 5(g). Such notice may instruct the Company to deliver shares of Company
Stock due upon the exercise of the Stock Option to any registered broker or
dealer designated by the Committee in lieu of delivery to the Grantee, in which
case such instructions must also designate the account into which the shares are
to be deposited.
(f) Termination of Employment, Disability or Death.
(1) In the event that a Grantee ceases to be an employee of
the Company for any reason other than "disability", death or "termination for
cause", any Stock Option which is otherwise vested and exercisable by the
Grantee shall terminate unless exercised within thirty (30) days of the date on
which the Grantee ceases to be an employee of the Company (or within such other
period of time as may be specified in the Grant Letter), but in any event no
later than the date of expiration of the option exercise period. Any of the
Grantee's Stock Options which are not otherwise vested and exercisable as of the
date on which the Grantee ceases to be an employee of the Company shall
terminate as of such date.
(2) In the event that a Grantee ceases to be an employee of
the Company on account of a "termination for cause" by the Company, any Stock
Option held by the Grantee shall terminate as of the date the Grantee ceases to
be an employee of the Company.
3
<PAGE> 26
(3) In the event that a Grantee ceases to be an employee of
the Company because the Grantee is "disabled", any Stock Option which is
otherwise vested and exercisable by the Grantee shall terminate unless exercised
within one (1) year of the date on which the Grantee ceases to be an employee of
the Company (or within such other period of time as may be specified in the
Grant Letter), but in any event no later than the date of expiration of the
option exercise period. Any of the Grantee's Stock Options which are not
otherwise vested and exercisable as of the date on which the Grantee ceases to
be an employee of the Company shall terminate as of such date.
(4) In the event of the death of a Grantee while the Grantee
is an employee of the Company or within not more than thirty (30) days of the
date on which the Grantee ceases to be an employee of the Company on account of
a termination of employment for any reason other than "termination for cause" or
"disability" (or within such other period of time as may be specified in the
Grant Letter), any Stock Option which is otherwise vested and exercisable by the
Grantee shall terminate unless exercised within one (1) year of the date on
which the Grantee ceases to be an employee of the Company (or within such other
period of time as may be specified in the Grant Letter), but in any event no
later than the date of expiration of the option exercise period. Any of the
Grantee's Stock Options which are not otherwise vested and exercisable as of the
date on which the Grantee ceases to be an employee of the Company shall
terminate as of such date.
(5) For purposes of this Section 5(f), the following terms
shall be defined as follows: (A) "disability" shall mean a Grantee's becoming
disabled within the meaning of section 22(e)(3) of the Code and (B) "termination
for cause" shall mean, except to the extent otherwise provided in a Grantee's
Grant Letter, a finding by the Committee, after full consideration of the facts
presented on behalf of both the Company and the Grantee, that the Grantee has
(i) breached his or her employment or service contract with the Company, or (ii)
has engaged in disloyalty to the Company, fraud, embezzlement, theft, commission
of a felony or proven dishonesty in the course of his or her employment by or
service to the Company, or (iii) has disclosed trade secrets or other
confidential information of the Company to persons not entitled to receive the
same. In the event of a finding by the Committee of "termination for cause" with
respect to a Grantee, in addition to the immediate termination of all Stock
Options held by such Grantee, the Grantee shall automatically forfeit all option
shares for any exercised portion of a Stock Option for which the Company has not
yet delivered the share certificates upon refund by the Company of the option
price paid by the Grantee for such option shares.
(g) Satisfaction of Option Price. The Grantee shall pay the option
price specified in the Grant Letter in (i) cash, (ii) with the approval of the
Committee, by delivering shares of Company Stock owned by the Grantee (including
Company Stock acquired in connection with the exercise of a Stock Option),
subject to such restrictions as the Committee deems appropriate, and having a
Fair Market Value on the date of exercise equal to the option price or (iii)
through any combination of (i) and (ii). The Grantee shall pay the option price
and the amount of withholding tax due, if any, at the time of exercise. Shares
of Company Stock shall not be issued or transferred upon exercise of a Stock
Option until the option price is fully paid and any required withholding is
made.
(h) Limits on Incentive Stock Options. Each Incentive Stock Option
shall provide that, if the aggregate Fair Market Value on the date of the Grant
of the Company Stock with respect to which Incentive Stock Options are
exercisable for the first time by a Grantee during any calendar year (under the
Plan or any other stock option plan of the Company or a parent or subsidiary
corporation) exceeds $100,000, then such option, as to the excess, shall be
treated as a Nonqualified Stock Option.
(i) Option Grants to Non-Employee Directors. The Committee may grant
such Nonqualified Stock Options as it deems appropriate to Non-Employee
Directors. Unless the Committee determines otherwise, Nonqualified Stock Options
shall be granted annually to Non-Employee Directors with the following terms:
(i) On the date of each annual meeting of the shareholders of
the Company, beginning with the 1998 annual meeting, each Non-Employee Director
who is elected to the Board or who continues his or her term on the Board on
that date shall receive a Nonqualified Stock Option to purchase 1,000 shares of
Company Stock.
4
<PAGE> 27
The option price for the Stock Options shall be equal to the Fair Market Value
of a share of Company Stock on the date of the annual shareholders' meeting. The
Stock Options shall be fully vested on the date of grant and shall have a term
of ten years.
(ii) If a Grantee ceases to be a member of the Board for any
reason other than "disability" (as defined in subsection (f) above), death or
becoming an employee of the Company, the Grantee's Stock Options shall terminate
unless exercised within ninety (90) days of the date on which the Grantee ceases
to be a member of the Board (or within such other period of time as may be
specified in the Grant Letter), but in any event no later than the date of
expiration of the option exercise period. If the Grantee ceases to be a member
of the Board because he or she is "disabled," the Grantee's Stock Options shall
terminate unless exercised within one year of the date on which the Grantee
ceases to be a member of the Board (or within such other period of time as may
be specified in the Grant Letter), but in any event no later than the expiration
of the option exercise period. In the event of the death of a Grantee while the
Grantee is a member of the Board or within not more than ninety (90) days of the
date on which the Grantee ceases to be a member of the Board for any reason
other than "disability" (or within such other period of time as may be specified
in the Grant Letter), the Grantee's Stock Options shall terminate unless
exercised within one year of the date on which the Grantee ceases to be a member
of the Board (or within such other period of time as may be specified in the
Grant Letter), but in any event no later than the date of expiration of the
option exercise period. If the Grantee ceases to be a member of the Board but
becomes or remains an Employee of the Company, the Grantee's Stock Options shall
remain in effect until the Grantee is no longer an Employee or member of the
Board (but not later than the expiration date of the option exercise period), at
which time the foregoing provisions shall apply as if the Grantee had then
ceased to be a member of the Board.
(iii) In other respects, the provisions of the foregoing
paragraphs of this Section 5 applicable to Nonqualified Stock Options shall
apply to Stock Options granted to Non-Employee Directors.
6. Restricted Stock Grants
The Committee may issue or transfer shares of Company Stock to an
Employee under a Grant (a "Restricted Stock Grant"), upon such terms as the
Committee deems appropriate. The following provisions are applicable to
Restricted Stock Grants:
(a) General Requirements. Shares of Company Stock issued or transferred
pursuant to Restricted Stock Grants may be issued or transferred for
consideration or for no consideration, at the sole discretion of the Committee.
The Committee shall establish conditions under which restrictions on the
transfer of shares of Company Stock shall lapse over a period of time or
according to such other criteria as the Committee deems appropriate. The period
of years during which the Restricted Stock Grant will remain subject to
restrictions will be designated in the Grant Letter as the "Restriction Period."
(b) Number of Shares. The Committee shall issue or transfer to each
Grantee of a Restricted Stock Grant such number of shares of restricted Company
Stock as the Committee deems appropriate.
(c) Requirement of Employment. If a Grantee's employment terminates
during the period designated in the Grant Letter as the Restriction Period, or
if other specified conditions are not met, the Restricted Stock Grant shall
terminate as to all shares covered by the Grant as to which the restrictions on
transfer have not lapsed, and those shares of Company Stock must be immediately
returned to the Company. The Committee may, however, provide for complete or
partial exceptions to this requirement as it deems equitable.
(d) Restrictions on Transfer and Legend on Share Certificate. During
the Restriction Period, a Grantee may not sell, assign, transfer, pledge or
otherwise dispose of the shares of Company Stock to which such Restriction
Period applies except to a Successor Grantee under Section 8(a). Each
certificate for shares issued or transferred under a Restricted Stock Grant
shall contain a legend giving appropriate notice of the restrictions in the
Grant. The Grantee shall be entitled to have the legend removed from the share
certificate covering any of the
5
<PAGE> 28
shares subject to restrictions when all restrictions on such shares have lapsed.
The Committee, in its sole discretion, may determine that the Company will not
issue certificates for shares of Restricted Stock until all restrictions on such
shares have lapsed, or that the Company will retain possession of certificates
for shares of Restricted Stock until all restrictions on such shares have
lapsed.
(e) Right to Vote and to Receive Dividends. During the Restriction
Period, unless the Committee determines otherwise, the Grantee shall have the
right to vote shares subject to the Restricted Stock Grant and to receive any
dividends or other distributions paid on such shares, subject to any
restrictions deemed appropriate by the Committee.
(f) Lapse of Restrictions. All restrictions imposed under a Restricted
Stock Grant shall lapse upon the expiration of the applicable Restriction Period
and the satisfaction of any conditions imposed by the Committee. The Committee
may determine, as to any or all Restricted Stock Grants, that all the
restrictions shall lapse without regard to any Restriction Period. All
outstanding Restricted Stock Grants shall vest upon a Change of Control, unless
the Committee determines otherwise pursuant to Section 10.
7. Stock Appreciation Rights
(a) The Committee may grant stock appreciation rights ("SARs") to any
Grantee in tandem with any Stock Option, for all or a portion of the applicable
Stock Option, either at the time the Stock Option is granted or at any time
thereafter while the Stock Option remains outstanding; provided, however, that
in the case of an Incentive Stock Option, such rights may be granted only at the
time of the Grant of such Incentive Stock Option. Unless the Committee
determines otherwise, the base price of each SAR shall be equal to the greater
of (i) the exercise price of the related Stock Option or (ii) the Fair Market
Value of a share of Company Stock as of the date of Grant of such SAR.
(b) The number of SARs granted to a Grantee which shall be exercisable
during any given period of time shall not exceed the number of shares of Company
Stock which the Grantee may purchase upon the exercise of the related Stock
Option during such period of time. Upon the exercise of a Stock Option, the SARs
relating to the Company Stock covered by such Stock Option shall terminate. Upon
the exercise of SARs, the related Stock Option shall terminate to the extent of
an equal number of shares of Company Stock.
(c) Upon a Grantee's exercise of some or all of the Grantee's SARs, the
Grantee shall receive in settlement of such SARs an amount equal to the value of
the stock appreciation for the number of SARs exercised, payable in cash,
Company Stock or a combination thereof. The stock appreciation for an SAR is the
difference between the base price of the SAR as described in Section 7(a) and
the Fair Market Value of the underlying Company Stock on the date of exercise of
such SAR.
(d) At the time of such exercise, the Grantee shall have the right to
elect the portion of the amount to be received that shall consist of cash and
the portion that shall consist of Company Stock, which, for purposes of
calculating the number of shares of Company Stock to be received, shall be
valued at their Fair Market Value on the date of exercise of such SARs. The
Committee shall have the right to disapprove a Grantee's election to receive
cash in full or partial settlement of the SARs exercised and to require that
shares of Company Stock be delivered in lieu of cash. If shares of Company Stock
are to be received upon exercise of an SAR, cash shall be delivered in lieu of
any fractional share. A SAR shall be exercisable only during the period when the
Stock Option to which it is related is also exercisable.
8. Transferability of Grants
(a) Only the Grantee or a Successor Grantee (as defined below) may
exercise rights under a Grant. Such persons may not transfer those rights,
except that a Grantee may transfer rights under a Grant by will or by the laws
of descent and distribution or, with respect to Grants other than Incentive
Stock Options, if permitted under
6
<PAGE> 29
Rule 16b-3 of the Exchange Act and if permitted in any specific case by the
Committee in its sole discretion, pursuant to a domestic relations order as
defined under the Code or Title I of the Employee Retirement Income Security Act
of 1974, as amended, or the regulations thereunder. When a Grantee dies, the
representative or other person entitled to succeed to the rights of the Grantee
("Successor Grantee") may exercise such rights. A Successor Grantee must furnish
proof satisfactory to the Company of his or her right to receive the Grant under
the Grantee's will or under the applicable laws of descent and distribution.
(b) Notwithstanding the foregoing, the Committee may provide, in a
Grant Letter, that a Grantee may transfer Nonqualified Stock Options to family
members or other persons or entities according to such terms as the Committee
may determine.
9. Change of Control of the Company
As used herein, a "Change of Control" shall be deemed to have occurred
if:
(a) A liquidation or dissolution of the Company or the sale (excluding
transfers to subsidiaries) of all or substantially all of the Company's assets
occurs;
(b) As a result of a tender offer, stock purchase, other stock
acquisition, merger, consolidation, recapitalization, reverse split or sale or
transfer of assets, any person or group (as such terms are used in and under
Section 13(d) of the Exchange Act) becomes the beneficial owner (as defined in
Rule 13-d under the Exchange Act), directly or indirectly, of securities of the
Company representing more than 20% of the common stock of the Company or the
combined voting power of the Company's then outstanding securities; or
(c) During any period of two consecutive years, individuals who, at the
beginning of such period, constitute the Board cease for any reason to
constitute at least a majority thereof, unless the election, or the nomination
for election by the Company's shareholders, of at least two-thirds of the
directors who were not directors at the beginning of such period was approved by
a vote of at least two-thirds of the directors then still in office who were
either directors at the beginning of the period or who, in connection with their
election or nomination, received the foregoing two-thirds approval.
10. Consequences of a Change of Control
(a) Upon a Change of Control, unless the Committee determines
otherwise, (i) the Company shall provide to each Grantee who holds an
outstanding Grant written notice of such Change of Control, (ii) all outstanding
Stock Options and SARs shall automatically accelerate and become fully
exercisable, and (iii) the restrictions and conditions on all outstanding
Restricted Stock shall immediately lapse. Notwithstanding the foregoing, if a
Change of Control described in Section 9(a) will occur, or if a Change of
Control described in Section 9(b) will occur and the Company will not be the
surviving corporation (or will survive only as a subsidiary of another
corporation), then the provisions of this Section 10(a) shall be mandatory,
subject to the provisions of Section 10(d) below.
(b) In the event of a Change of Control where the Company is not the
surviving corporation (or survives only as a subsidiary of another corporation),
unless the Committee determines otherwise, all outstanding Stock Options and
SARs that are not exercised shall be assumed by, or replaced with comparable
options or rights by, the surviving corporation.
(c) In addition, in the event of a Change of Control, the Committee may
take one or both of the following actions: the Committee may (i) require that
Grantees surrender their outstanding Stock Options and SARs in exchange for a
payment by the Company, in cash or Company Stock as determined by the Committee,
in an amount equal to the amount by which the then Fair Market Value of the
shares of Company Stock subject to the
7
<PAGE> 30
Grantee's outstanding Stock Options and SARs exceeds the purchase price of the
Options or the base price of the SARs, as applicable, or (ii) after giving
Grantees an opportunity to exercise their outstanding Stock Options and SARs,
terminate any or all outstanding Stock Options and SARs at such time as the
Committee deems appropriate. Such surrender or termination shall take place as
of the date of the Change of Control or such other date as the Committee may
specify.
(d) Notwithstanding anything in the Plan to the contrary, in the event
of a Change of Control, the Committee shall not have the right to take any
actions described in the Plan (including without limitation actions described in
Section 10(c) above) that would make the Change of Control ineligible for
pooling of interest accounting treatment or that would make the Change of
Control ineligible for desired tax treatment if, in the absence of such right,
the Change of Control would qualify for such treatment and the Company intends
to use such treatment with respect to the Change of Control.
(e) The Committee may make determinations under this Section 10 prior
to the Change of Control or, if the Committee making such determinations
following a Change of Control is comprised of the same members as served on the
Committee immediately prior to such Change of Control, within twenty (20) days
following such Change of Control.
11. Amendment and Termination of the Plan
(a) Amendment. The Board may amend or terminate the Plan at any time;
provided, however, that any amendment that increases the aggregate number (or
individual limit for any single Grantee) of shares of Company Stock that may be
issued or transferred under the Plan (other than by operation of Section 3(b)),
or modifies the requirements as to eligibility for participation in the Plan,
shall be subject to approval by the shareholders of the Company and provided,
further, that the Board shall not amend the Plan without shareholder approval if
such approval is required by Section 162(m) of the Code.
(b) Termination of Plan. The Plan shall terminate on May 9, 2006 unless
terminated earlier by the Board or unless extended by the Board with the
approval of the shareholders.
(c) Termination and Amendment of Outstanding Grants. A termination or
amendment of the Plan that occurs after a Grant is made shall not materially
impair the rights of a Grantee under such Grant unless the Grantee consents or
unless the Committee acts under Section 19(b). The termination of the Plan shall
not impair the power and authority of the Committee with respect to any
outstanding Grant. Whether or not the Plan has terminated, an outstanding Grant
may be terminated or amended under Section 19(b) or may be amended by agreement
of the Company and the Grantee consistent with the Plan.
(d) Governing Document. The Plan shall be the controlling document. No
other statements, representations, explanatory materials or examples, oral or
written, may amend the Plan in any manner. The Plan shall be binding upon and
enforceable against the Company and its successors and assigns.
12. Funding of the Plan
The Plan shall be unfunded. The Company shall not be required to
establish any special or separate fund or to make any other segregation of
assets to assure the payment of any Grants under the Plan. In no event shall
interest be paid or accrued on any Grant, including unpaid installments of
Grants.
13. Rights of Participants
Nothing in the Plan shall entitle any Employee or other person to any
claim or right to be granted a Grant under the Plan. Neither the Plan nor any
action taken hereunder shall be construed as giving any individual any rights to
be retained by or in the employ of the Company or any other employment rights.
8
<PAGE> 31
14. No Fractional Shares
No fractional shares of Company Stock shall be issued or delivered
pursuant to the Plan or any Grant. The Committee shall determine whether cash,
other awards or other property shall be issued or paid in lieu of such
fractional shares or whether such fractional shares or any rights thereto shall
be forfeited or otherwise eliminated.
15. Withholding of Taxes
(a) The Company shall have the right to deduct from all Grants paid in
cash, or from other wages paid to a Grantee, any federal, state or local taxes
required by law to be withheld with respect to such cash awards and, in the case
of Grants paid in Company Stock, the Grantee or other person receiving such
shares shall be required to pay to the Company the amount of any such taxes
which the Company is required to withhold with respect to such Grants or the
Company shall have the right to deduct from other wages paid to the Grantee by
the Company the amount of any withholding due with respect to such Grants.
(b) If the Committee so permits, a Grantee may elect to satisfy the
Company's income tax withholding obligation with respect to a Grant paid in
Company Stock by having shares withheld up to an amount that does not exceed the
Grantee's maximum marginal tax rate for federal (including FICA), state and
local tax liabilities. The election must be in a form and manner prescribed by
the Committee and shall be subject to the prior approval of the Committee.
16. Requirements for Issuance or Transfer of Shares
No Company Stock shall be issued or transferred in connection with any
Grant hereunder unless and until all legal requirements applicable to the
issuance or transfer of such Company Stock have been complied with to the
satisfaction of the Committee. The Committee shall have the right to condition
any Grant made to any Grantee hereunder on such Grantee's undertaking in writing
to comply with such restrictions on his or her subsequent disposition of such
shares of Company Stock as the Committee shall deem necessary or advisable as a
result of any applicable law, regulation or official interpretation thereof and
certificates representing such shares may be legended to reflect any such
restrictions. Certificates representing shares of Company Stock issued or
transferred under the Plan will be subject to such stop-transfer orders and
other restrictions as may be applicable under such laws, regulations and other
obligations of the Company, including any requirement that a legend or legends
be placed thereon.
17. Headings
Section headings are for reference only. In the event of a conflict
between a title and the content of a Section, the content of the Section shall
control. References herein to a Section or a Subsection are references to
Sections or Subsections of the Plan unless otherwise noted.
18. Effective Date of the Plan
The Plan became effective on May 10, 1996 when it was approved by the
Company's shareholders.
19. Miscellaneous
(a) Substitute Grants. The Committee may make a Grant to an employee of
another corporation who becomes an Employee by reason of a corporate merger,
consolidation, acquisition of stock or property, reorganization or liquidation
involving the Company or any of its subsidiaries in substitution for a stock
option or restricted stock grant made by such corporation ("Substituted Stock
Incentives"). The terms and conditions of the substitute grant may vary from the
terms and conditions required by the Plan and from those of the Substituted
Stock Incentives. The Committee shall prescribe the provisions of the substitute
grants.
9
<PAGE> 32
(b) Compliance with Law. The Plan, the exercise of Stock Options and
the obligation of the Company to issue or transfer shares of Company Stock under
Grants shall be subject to all applicable laws and to approvals by any
governmental or regulatory agency as may be required. With respect to persons
subject to Section 16 of the Exchange Act, it is the intent of the Company that
the Plan and all transactions under the Plan comply with all applicable
provisions of Rule 16b-3 or its successors under the Exchange Act. The Committee
may revoke any Grant if it is contrary to law or modify a Grant to bring it into
compliance with any valid and mandatory government regulation. The Committee may
also adopt rules regarding the withholding of taxes on payments to Grantees. The
Committee may, in its sole discretion, agree to limit its authority under this
Section 19(b).
(c) Ownership of Stock. A Grantee or Successor Grantee shall have no
rights as a shareholder with respect to any shares of Company Stock covered by a
Grant until the shares are issued or transferred to the Grantee or Successor
Grantee on the stock transfer records of the Company.
(d) Governing Law. The validity, construction, interpretation and
effect of the Plan and Grant Letters issued under the Plan shall exclusively be
governed by and determined in accordance with the law of the State of New
Jersey.
10
<PAGE> 33
K-TRON INTERNATIONAL, INC. PROXY
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS. The undersigned
hereby appoints LEO C. BEEBE and EDWARD B. CLOUES, II, or either of them acting
singly in the absence of the other, each with the power to appoint his
substitute, the Proxy Agents of the undersigned to attend the Annual Meeting of
Shareholders of K-Tron International, Inc. (the "Company") to be held at the
Rosemont Suites Hotel O'Hare, 5500 N. River Road, Rosemont, Illinois, on May 5,
1998, at 10:00 a.m., local time, and any adjournments thereof, and with all
powers the undersigned would possess if personally present, to vote upon the
following matters as indicated below.
(CONTINUED AND TO BE SIGNED ON REVERSE SIDE.)
PLEASE MARK, SIGN AND DATE THIS PROXY CARD AND PROMPTLY RETURN IT USING
THE ENCLOSED ENVELOPE.
-----------
SEE REVERSE
SIDE
-----------
<PAGE> 34
Please mark your
[X] votes as in this
example
FOR WITHHELD
1. Election of NOMINEES: Hans-Jurg Schurmann,
Directors [ ] [ ] Jean Head Sisco
Class I
For, except vote withheld from the following nominee(s):
____________________________________________________________________________
FOR AGAINST ABSTAIN
2. Approval of an amendment to and
restatement of the Company's 1996 [ ] [ ] [ ]
Equity Compensation Plan
FOR AGAINST ABSTAIN
3. Approval of an increase in the number of
authorized shares of Common Stock [ ] [ ] [ ]
under the Company's Restated Certificate
of Incorporation
4. In their discretion, the Proxy Agents are authorized to vote upon such other
business that may properly come before the meeting.
THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY
THE UNDERSIGNED SHAREHOLDER. IF NO INSTRUCTION IS SPECIFIED WITH RESPECT TO A
MATTER TO BE ACTED UPON, THE SHARES REPRESENTED BY THE PROXY WILL BE VOTED FOR
ALL NOMINEES FOR ELECTION AS THE CLASS I DIRECTORS, FOR AN AMENDMENT TO AND
RESTATEMENT OF THE COMPANY'S 1996 EQUITY COMPENSATION PLAN AND FOR AN INCREASE
IN THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK UNDER THE COMPANY'S RESTATED
CERTIFICATE OF INCORPORATION. IF ANY OTHER BUSINESS IS PRESENTED AT THE MEETING,
THIS PROXY CONFERS AUTHORITY TO AND SHALL BE VOTED IN ACCORDANCE WITH THE
RECOMMENDATION OF THE BOARD OF DIRECTORS OF THE COMPANY OR ITS EXECUTIVE
COMMITTEE. THE UNDERSIGNED HEREBY ACKNOWLEDGES RECEIPT OF THE NOTICE OF THE
ANNUAL MEETING OF SHAREHOLDERS AND THE RELATED PROXY STATEMENT.
PLEASE MARK, SIGN AND DATE THIS PROXY CARD AND PROMPTLY RETURN IT USING THE
ENCLOSED ENVELOPE.
SIGNATURE(S)_______________________________________________ DATE_________, 1998
Please sign exactly as name appears above. When shares are held by joint
tenants, both should sign. When signing as attorney, executor, administrator,
trustee or guardian, please give full title as such. If a corporation, please
sign in full corporate name by the President or other authorized officer. If a
partnership, please sign in the partnership name by an authorized person.
